SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/700CA015A6730436CFFA3268743DD02DF93517076E2D7E66864B7EFC56CDC5C87186EA870579DFCA7C3C85DF8C3A7882>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/700CA015A6730436CFFA3268743DD02DF93517076E2D7E66864B7EFC56CDC5C87186EA870579DFCA7C3C85DF8C3A7882
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/700CA015A6730436CFFA3268743DD02DF93517076E2D7E66864B7EFC56CDC5C87186EA870579DFCA7C3C85DF8C3A7882
http://www.w3.org/2000/01/rdf-schema#comment
"Specific VEGFR3 expression examined in 27 B-CLL samples was positive in 26 of them. The VEGF transduction pathway may be very active in CLL cells. Both its paracrine & autocrine pathways may contribute to their enhanced survival."
xsd:string
http://purl.uniprot.org/uniprot/#_DCF0429B57B7ED5C7CC5C9A9EAC72FEE31CD887668D09D63FB22786CF0D8EBB2434A5C5EB51C960CBD480A11EAE4E26A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/700CA015A6730436CFFA3268743DD02DF93517076E2D7E66864B7EFC56CDC5C87186EA870579DFCA7C3C85DF8C3A7882
http://purl.uniprot.org/uniprot/B5A928
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/700CA015A6730436CFFA3268743DD02DF93517076E2D7E66864B7EFC56CDC5C87186EA870579DFCA7C3C85DF8C3A7882
http://purl.uniprot.org/uniprot/#_B5A928-mappedCitation-14687619
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/700CA015A6730436CFFA3268743DD02DF93517076E2D7E66864B7EFC56CDC5C87186EA870579DFCA7C3C85DF8C3A7882